IP Library Granted Patent US 11,045,338
Granted Patent B2
US 11,045,338 · App. 15/397,334 · Granted Jun 29, 2021

Implantable expandable medical devices having regions of differential mechanical properties and methods of making same

Inventors: Christopher T. Boyle (Flushing, NY); Christopher E. Banas (Breckenridge, CO); Denes Marton (San Antonio, TX)
Assignee: Vactronix Scientific
A61F2/915A61F2/89A61F2/91A61L31/022A61L31/14A61F2002/91541A61F2002/91558A61F2002/91575A61F2210/0014A61F2210/0023A61F2220/0091A61F2250/0042
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,045,338
App. No.
15/397,334
Granted
Jun 29, 2021
Kind
B2
Abstract

An implantable expandable medical device in which selected regions of the device are in a martensite phase and selected regions are in an austenite phase. The martensitic regions exhibit pseudoplastic behavior in vivo and may be deformed without recovery under in vivo body conditions. In contrast the austenitic regions exhibit superelastic behavior in vivo and will recover their pre-programmed configuration upon deformation or release of an applied strain.

Claims (24)

1. An implantable medical device made of a biocompatible metal alloy, comprising:

a plurality of circumferential ring members made of the biocompatible metal alloy and having a first chemical stoichiometry, the plurality of circumferential ring members comprising a plurality of strut members that are in an austenite phase in vivo, wherein the austenite phase of the plurality of strut members accommodates radial self-expansion of the circumferential ring members under in vivo conditions;

a plurality of interconnecting members made of the biocompatible metal alloy and having a second chemical stoichiometry and interconnecting adjacent circumferentially expansible ring members, the plurality of interconnecting members comprising a second plurality of strut members that are in the martensite phase in vivo, wherein the martensite phase of the second plurality of strut members accommodates substantially non-recoverable longitudinal expansion of the implantable medical device under in vivo conditions;

wherein the medical device can be loaded to at least 8% strain with a loading plateau of at least 600 MPa and is fully recoverable by unloading to 0% strain with an unloading plateau of at least 300 MPa.

2. The implantable medical device of claim 1 wherein the plurality of interconnecting members have a substantially non-recoverable deformation of less than 1% upon application of a deforming load.

3. The implantable medical device of claim 1 wherein the plurality of interconnecting members have a longitudinal elastic recoil less than 20% when the device is flexed along a longitudinal axis.

4. The implantable medical device according to claim 1 , wherein the biocompatible metal alloy is a nickel-titanium alloy.

5. The implantable medical device of claim 4 wherein second chemical stoichiometry comprises a greater composition of titanium relative to the first chemical stoichiometry.

6. The implantable medical device of claim 4 wherein second chemical stoichiometry comprises a lesser composition of nickel relative to the first chemical stoichiometry.

7. The implantable medical device of claim 1 wherein the medical device is loaded to an 8% strain with a loading plateau at about 200 MPa and a peak loading at about 400-600 MPa and while unloading the biocompatible metal alloy, there remains a residual strain in of about 7% strain in the biocompatible metal alloy.

8. The implantable medical device according to claim 1 , wherein the plurality of circumferential ring members are sufficiently austenitic under in vivo conditions to allow at least about 90% recovery of an unstrained configuration of the device.

9. The implantable medical device according to claim 1 , wherein the plurality of interconnecting members further have a higher transition temperature than the remainder of the implantable medical device.

10. An implantable medical device made of a biocompatible metal alloy comprising:

a plurality of first members made of the biocompatible metal alloy and having a first chemical stoichiometry that are in an austenitic phase in vivo, wherein the plurality of first members are sufficiently austenitic to permit self-deformation under in vivo conditions; and

a plurality of second members made of the biocompatible metal alloy and having a second chemical stoichiometry interconnecting the plurality of first members, the plurality of second members are martensitic in vivo sufficient to permit substantially non-recoverable deformation of the plurality of second members under in vivo conditions;

wherein the medical device can be loaded to at least 8% strain with a loading plateau of at least 600 MPa and is fully recoverable by unloading to 0% strain with an unloading plateau of at least 300 MPa.

11. The implantable medical device of claim 10 wherein the plurality of second members have a substantially non-recoverable deformation of less than 1% upon application of a deforming load.

12. The implantable medical device of claim 10 wherein the plurality of second members have an elastic recoil less than 20% when the medical device is flexed along a longitudinal axis of the medical device.

13. The implantable medical device according to claim 10 , wherein the biocompatible metal alloy is a nickel-titanium alloy.

14. The implantable medical device of claim 13 wherein second chemical stoichiometry comprises a greater composition of titanium relative to the first chemical stoichiometry.

15. The implantable medical device of claim 13 wherein second chemical stoichiometry comprises a lesser composition of nickel relative to the first chemical stoichiometry.

16. The implantable medical device according to claim 10 , wherein the plurality of first members are sufficiently austenitic under in vivo conditions to allow at least about 90% recovery of an unstrained configuration of the device.

17. The implantable medical device according to claim 10 , wherein the plurality of second members further have a higher transition temperature than the remainder of the implantable medical device.

18. The implantable medical device of claim 10 wherein the medical device is loaded to an 8% strain with a loading plateau at about 200 MPa and a peak loading at about 400-600 MPa and while unloading the biocompatible metal alloy, there remains a residual strain in of about 7% strain in the biocompatible metal alloy.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2018
From: VACTRONIX SCIENTIFIC, INC.
To: VACTRONIX SCIENTIFIC, LLC
Reel/Frame 046203/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2018
From: ADVANCED BIO PROSTHETIC SURFACES, LTD., A WHOLLY OWNED SUBSIDIARY OF PALMAZ SCIENTIFIC, INC.
To: VACTRONIX SCIENTIFIC, INC.
Reel/Frame 045709/0763 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2018
From: BOYLE, CHRISTOPHER T.; BANAS, CHRISTOPHER E; MARTON, DENES
To: ADVANCED BIO PROSTHETIC SURFACES, LTD.
Reel/Frame 045383/0933 →